From the College of Pharmacy, Ajou University, Suwon, Korea (J.Y.K., S.-H.S., J.-E.I., K.K., S.K., W.S.); Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea (J.-S.C., C.-K.J.); Department of Molecular and Life Science, CHA University, Seoul, Korea (J.-M.K.); Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University, Gyeongnam, Korea (H.K.S.); and Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Korea (B.H.L.).
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1459-67. doi: 10.1161/ATVBAHA.114.303575. Epub 2014 May 1.
Although stem cell factor (SCF) has been shown to play a critical role in hematopoiesis, gametogenesis, and melanogenesis, the function of SCF in the regulation of vascular integrity has not been studied.
We demonstrated that SCF binds to and activates the cKit receptor in endothelial cells, thereby increasing the internalization of vascular endothelial-cadherin and enhancing extravasation of dyes to a similar extent as vascular endothelial growth factor. SCF-mediated cKit activation in endothelial cells enhanced the phosphorylation of endothelial nitric oxide (NO) synthase via the phosphoinositide 3-kinase/Akt signaling pathway and subsequently increased the production of NO. Inhibition of endothelial NO synthase expression and NO synthesis using small interfering RNA knockdown and chemical inhibitors substantially diminished the ability of SCF to increase the internalization of vascular endothelial-cadherin and in vitro endothelial permeability. SCF-induced increase in extravasation of the dyes was abrogated in endothelial NO synthase knockout mice, which indicates that endothelial NO synthase-mediated NO production was responsible for the SCF-induced vascular leakage. Furthermore, we demonstrated that the expression of SCF and cKit was significantly higher in the retina of streptozotocin-injected diabetic mice than in the nondiabetic control animals. Depletion of SCF by intravitreous injection of anti-SCF-neutralizing immunoglobulin G significantly prevented vascular hyperpermeability in the retinas of streptozotocin-injected diabetic mice.
Our data reveal that SCF disrupts the endothelial adherens junction and enhances vascular leakage, as well as suggest that anti-SCF/cKit therapy may hold promise as a potential therapy for the treatment of hyperpermeable vascular diseases.
虽然干细胞因子 (SCF) 已被证明在造血、配子发生和黑色素生成中发挥关键作用,但 SCF 在调节血管完整性方面的功能尚未得到研究。
我们证明 SCF 在血管内皮细胞中结合并激活 cKit 受体,从而增加血管内皮钙黏蛋白的内化,并以与血管内皮生长因子相似的程度增强染料的渗出。SCF 介导的内皮细胞中 cKit 的激活通过磷酸肌醇 3-激酶/Akt 信号通路增强内皮型一氧化氮合酶 (eNOS) 的磷酸化,随后增加一氧化氮 (NO) 的产生。使用小干扰 RNA 敲低和化学抑制剂抑制内皮型一氧化氮合酶表达和 NO 合成,可显著降低 SCF 增加血管内皮钙黏蛋白内化和体外内皮通透性的能力。内皮型一氧化氮合酶敲除小鼠中 SCF 诱导的染料渗出增加被阻断,这表明内皮型一氧化氮合酶介导的 NO 产生是 SCF 诱导的血管渗漏的原因。此外,我们证明链脲佐菌素注射糖尿病小鼠视网膜中 SCF 和 cKit 的表达明显高于非糖尿病对照动物。玻璃体内注射抗 SCF 中和免疫球蛋白 G 耗竭 SCF 可显著预防链脲佐菌素注射糖尿病小鼠视网膜中的血管高通透性。
我们的数据揭示了 SCF 破坏内皮细胞黏附连接并增强血管渗漏,并表明抗 SCF/cKit 治疗可能有希望成为治疗高通透性血管疾病的潜在治疗方法。